Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon

  • R. Katherine Alpaugh
  • , Margaret Von Mehren
  • , Irma Palazzo
  • , Michael B. Atkins
  • , Joseph A. Sparano
  • , Lynn Schuchter
  • , Louis M. Weiner
  • , Janice P. Dutcher

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Nursing and Health Professions

Medicine and Dentistry